title: Gemcitabine is ineffective in recurrent, preirradiated cervical cancer.
authors.forename: S
authors.initials: S
authors.lastname: Greggi
authors.forename: G
authors.initials: G
authors.lastname: D'Agostino
authors.forename: D
authors.initials: D
authors.lastname: Smaniotto
authors.forename: D
authors.initials: D
authors.lastname: Genovesi
authors.forename: D
authors.initials: D
authors.lastname: Lorusso
authors.forename: G
authors.initials: G
authors.lastname: Scambia
mesh_terms: D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D018450:Disease Progression; D018572:Disease-Free Survival; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy* / Q000473:pathology; D000093542:Gemcitabine
chemical_list: D000964:Antimetabolites, Antineoplastic; D003841:Deoxycytidine; D016179:Granulocyte Colony-Stimulating Factor; D000093542:Gemcitabine